Just Accepted

This article has been peer reviewed and accepted for publication. It is in production and has not been edited, so may differ from the final published form.

Disulfide-Rich Peptides as Next-Generation Radiopharmaceuticals

Joshua Dilly , Benjamin Savage , Conan K. Wang

Abstract

Peptides are emerging as a preferred targeting agent for many radiopharmaceutical targets due to several favourable characteristics, including high tissue penetration and target specificity. Among them, disulfide-rich peptides stand out for their exceptional intrinsic stability, making them particularly well-suited for further development in this field – yet they remain underexplored. This review highlights examples where disulfide-rich peptides have been used in radiopharmaceuticals for imaging and therapy. We compare them to recently approved peptide radiopharmaceuticals to provide context and support for the broader use of disulfide-rich peptides for targeted delivery of radiation. Future directions are also discussed, including how emerging technologies can be applied to the discovery of new disulfide-rich peptide radiopharmaceuticals.

CH25096  Accepted 01 October 2025

© CSIRO 2025